Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Rybicki

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|October 30, 2010
Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patientsRonald M Sobecks, Edward Copelan, Matt Kalaycio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2011
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT)Nelli Bejanyan, Brian J Bolwell, Aleksandr Lazaryan, et al.
Hematology/Oncology and Stem Cell Therapy|July 18, 2015
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancerBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
The American Journal of Hospice & Palliative Care|December 24, 2022
Response Rates to Methylnaltrexone in Hospitalized Cancer PatientsDavid Harris, David Kalir, Cory Chevalier, et al.
Transplantation and Cellular Therapy|January 25, 2022
Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell TransplantationSanghee Hong, Lisa Rybicki, Linda Mclellan, et al.
The American Journal of Surgical Pathology|October 15, 2005
Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breastErinn Downs-Kelly, James Pettay, David Hicks, et al.
Journal of Clinical Apheresis|June 8, 2011
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yieldHien K Duong, Brian J Bolwell, Lisa Rybicki, et al.
American Journal of Hematology|January 22, 2019
Progression with clinical features is associated with worse subsequent survival in multiple myelomaRajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, et al.
The American Journal of Surgical Pathology|January 26, 2013
Reproducibility of the villous component and high-grade dysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillanceDipti Mahajan, Erinn Downs-Kelly, Xiuli Liu, et al.
NPJ Genomic Medicine|December 22, 2017
Assessment of clinical workload for general and specialty genetic counsellors at an academic medical center: a tool for evaluating genetic counselling practicesBrandie Heald, Lisa Rybicki, Diane Clements, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|October 30, 2010
Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patientsRonald M Sobecks, Edward Copelan, Matt Kalaycio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2011
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT)Nelli Bejanyan, Brian J Bolwell, Aleksandr Lazaryan, et al.
Hematology/Oncology and Stem Cell Therapy|July 18, 2015
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancerBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
The American Journal of Hospice & Palliative Care|December 24, 2022
Response Rates to Methylnaltrexone in Hospitalized Cancer PatientsDavid Harris, David Kalir, Cory Chevalier, et al.
Transplantation and Cellular Therapy|January 25, 2022
Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell TransplantationSanghee Hong, Lisa Rybicki, Linda Mclellan, et al.
The American Journal of Surgical Pathology|October 15, 2005
Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breastErinn Downs-Kelly, James Pettay, David Hicks, et al.
Journal of Clinical Apheresis|June 8, 2011
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yieldHien K Duong, Brian J Bolwell, Lisa Rybicki, et al.
American Journal of Hematology|January 22, 2019
Progression with clinical features is associated with worse subsequent survival in multiple myelomaRajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, et al.
The American Journal of Surgical Pathology|January 26, 2013
Reproducibility of the villous component and high-grade dysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillanceDipti Mahajan, Erinn Downs-Kelly, Xiuli Liu, et al.
NPJ Genomic Medicine|December 22, 2017
Assessment of clinical workload for general and specialty genetic counsellors at an academic medical center: a tool for evaluating genetic counselling practicesBrandie Heald, Lisa Rybicki, Diane Clements, et al.
Pageof 12